ArticleAnnals of translational medicine2020

Ruxolitinib protects lipopolysaccharide (LPS)-induced sepsis through inhibition of nitric oxide production in mice.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.